Marker Therapeutics (MRKR) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Marker Therapeutics (MRKR) over the last 4 years, with Q3 2025 value amounting to $600000.0.
- Marker Therapeutics' Receivables - Net rose 10000.0% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $600000.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $9.5 million for FY2024, which is 180000.0% up from last year.
- According to the latest figures from Q3 2025, Marker Therapeutics' Receivables - Net is $600000.0, which was up 10000.0% from $1.3 million recorded in Q2 2025.
- Over the past 5 years, Marker Therapeutics' Receivables - Net peaked at $8.0 billion during Q1 2025, and registered a low of $300000.0 during Q3 2024.
- Moreover, its 4-year median value for Receivables - Net was $1.7 million (2023), whereas its average is $729.2 million.
- As far as peak fluctuations go, Marker Therapeutics' Receivables - Net tumbled by 4000.0% in 2024, and later skyrocketed by 66656666.67% in 2025.
- Quarter analysis of 4 years shows Marker Therapeutics' Receivables - Net stood at $2.0 million in 2022, then crashed by 75.0% to $500000.0 in 2023, then surged by 1800.0% to $9.5 million in 2024, then tumbled by 93.68% to $600000.0 in 2025.
- Its Receivables - Net stands at $600000.0 for Q3 2025, versus $1.3 million for Q2 2025 and $8.0 billion for Q1 2025.